Dr. Frimer on the Exploration of Maintenance with Niraparib in Uterine Serous Carcinoma
March 19th 2022Marina Frimer, MD, FACOG, FACS, discusses the exploration of maintenance with niraparib in a phase 2 trial in patients with advanced or platinum-sensitive recurrent uterine serious carcinoma
Read More